High-risk human papilloma virus infection, tumor pathophenotypes, and BRCA1/2 and TP53 status in juvenile breast cancer

By Aceto Gitana  

Breast Cancer Research and Treatment, Vol. 122, Iss. 3, 2010-08 ,pp. : 671-683

Springer Publishing Company

Access to resources Recommend Favorite

Two new CHEK2 germ-line variants detected in breast cancer/sarcoma families negative for BRCA1 , BRCA2 , and TP53 gene mutations

By Manoukian Siranoush  

Breast Cancer Research and Treatment, Vol. 130, Iss. 1, 2011-11 ,pp. : 207-215

Springer Publishing Company

Access to resources Recommend Favorite

Prevalence of germline TP53 mutations in HER2+ breast cancer patients

By Rath Michelle  

Breast Cancer Research and Treatment, Vol. 139, Iss. 1, 2013-05 ,pp. : 193-198

Springer Publishing Company

Access to resources Recommend Favorite

Glycodelin expression associates with differential tumour phenotype and outcome in sporadic and familial non-BRCA1/2 breast cancer patients

By Hautala Laura   Greco Dario   Koistinen Riitta   Heikkinen Tuomas   Heikkilä Päivi   Aittomäki Kristiina   Blomqvist Carl   Koistinen Hannu   Nevanlinna Heli  

Breast Cancer Research and Treatment, Vol. 128, Iss. 1, 2011-07 ,pp. : 85-95

Springer Publishing Company

Access to resources Recommend Favorite

Germ line BRCA1 and BRCA2 gene mutations in Turkish breast cancer patients

By Ozdag H.   Tez M.   Sayek I.   Muslumanoglu M.   Tarcan O.   Icli F.   Ozturk M.   Ozcelik T.  

European Journal of Cancer, Vol. 36, Iss. 16, 2000-10 ,pp. : 2076-2082

Elsevier

Access to resources Recommend Favorite